Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Disc Medicine
IRON
$2.81B
| $36.8M | 0.02% |
749,827
+303,954
| +68% | +$14.3M |
|
452
United Parcel Service
UPS
$88.9B
| $36.7M | 0.02% |
269,498
+180,519
| +203% | +$23.7M |
|
453
IQVIA
IQV
$40.7B
| $36.4M | 0.02% |
153,560
-3,993
| -3% | -$943K |
|
454
Larimar Therapeutics
LRMR
$377M
| $36.4M | 0.02% |
5,566,855
+1,189,467
| +27% | +$9.56M |
|
455
OneMain Financial
OMF
$7.27B
| $36.4M | 0.02% |
772,864
+315,640
| +69% | +$15.2M |
|
456
Perimeter Solutions
PRM
$5.66B
| $36.3M | 0.02% |
2,698,180
-1,653
| -0.1% | -$17.1K |
|
457
Cardinal Health
CAH
$53.7B
| $36.2M | 0.02% |
327,456
-63,942
| -16% | -$6.69M |
|
458
Bath & Body Works
BBWI
$3.97B
| $35.8M | 0.02% |
1,121,520
+559,851
| +100% | +$18.6M |
|
459
TriNet
TNET
$3.23B
| $35.6M | 0.02% |
367,475
-34,069
| -8% | -$3.39M |
|
|
PCH
460
DELISTED
PotlatchDeltic
PCH
| $35.1M | 0.02% |
778,559
-166,599
| -18% | -$7.05M |
|
461
Rocket Pharmaceuticals
RCKT
$343M
| $35.1M | 0.02% |
1,897,340
-1,021,738
| -35% | -$20.9M |
|
462
Paychex
PAYX
$43.4B
| $35M | 0.02% |
260,590
+200,640
| +335% | +$25.5M |
|
463
Martin Marietta Materials
MLM
$34.2B
| $34.7M | 0.02% |
64,518
| – | – |
|
464
CRA International
CRAI
$1.23B
| $34.7M | 0.02% |
197,922
+8,155
| +4% | +$1.36M |
|
465
SPDR Gold Trust
GLD
$131B
| $34.3M | 0.02% |
141,263
+2,464
| +2% | +$564K |
|
466
Lexeo Therapeutics
LXEO
$338M
| $34M | 0.02% |
3,763,195
+599,203
| +19% | +$7.15M |
|
467
4D Molecular Therapeutics
FDMT
$502M
| $33.9M | 0.02% |
3,137,087
-59,675
| -2% | -$990K |
|
468
Eagle Materials
EXP
$6.49B
| $33.9M | 0.02% |
117,819
-61,379
| -34% | -$15.3M |
|
469
CMS Energy
CMS
$23B
| $33.8M | 0.02% |
479,203
+440,000
| +1,122% | +$28.9M |
|
470
Air Products & Chemicals
APD
$65.5B
| $33.5M | 0.02% |
112,511
-68,722
| -38% | -$18.8M |
|
471
Piper Sandler
PIPR
$4.99B
| $33.5M | 0.02% |
471,732
-627,356
| -57% | -$41M |
|
472
OmniAb
OABI
$283M
| $33.3M | 0.02% |
7,871,328
+3,104
| +0% | +$13.4K |
|
473
FB Financial Corp
FBK
$2.98B
| $33.2M | 0.02% |
706,637
-423,322
| -37% | -$19M |
|
474
Napco Security Technologies
NSSC
$1.3B
| $33M | 0.02% |
816,264
-96,990
| -11% | -$4.75M |
|
475
Spyre Therapeutics
SYRE
$8.5B
| $32.9M | 0.02% |
1,120,531
+446,664
| +66% | +$12.4M |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.